Stem cell safety trial for liver cirrhosis
Part of Digestive system clinical trials.
This trial tests whether a type of stem cell therapy is safe for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. It may help if your liver disease is controlled and you have moderate to severe cirrhosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your liver cirrhosis must be caused by alcohol, hepatitis B, or hepatitis C.
- If your cirrhosis is from alcohol, you must have stopped drinking for at least 3 months.
- If you have hepatitis B or C, the virus must be under control per your doctor's standards.
- Your liver function must be moderately to severely affected (Child-Pugh score 7-12).
- You cannot have liver cancer, kidney failure, or other serious health problems listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from stem cells to see if it is safe and can help reduce scarring and improve liver function in people with liver cirrhosis. It focuses on patients with moderate liver disease (Child-Pugh Class B).
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This trial studies whether umbilical cord stem cells are safe for people with advanced (decompensated) hepatitis B cirrhosis. It mainly looks at safety and whether symptoms or quality of life improve after standard care has not helped enough.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
This trial tests if infusions of stem cells from donated umbilical cords can help people with a severe type of liver failure caused by hepatitis B. It aims to see if the treatment is safe and can improve liver function.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.